HomeCNTX • NASDAQ
add
Context Therapeutics Inc
Previous close
$1.80
Day range
$1.78 - $2.10
Year range
$0.53 - $2.10
Market cap
150.00M USD
Avg Volume
1.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.82M | -42.65% |
Net income | -3.67M | 41.86% |
Net profit margin | — | — |
Earnings per share | 0.23 | 157.50% |
EBITDA | -3.82M | 42.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.09M | -66.11% |
Total assets | 11.05M | -65.43% |
Total liabilities | 2.61M | -19.33% |
Total equity | 8.44M | — |
Shares outstanding | 75.00M | — |
Price to book | 3.40 | — |
Return on assets | -70.51% | — |
Return on capital | -94.11% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.67M | 41.86% |
Cash from operations | -4.36M | 23.88% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.36M | 23.88% |
Free cash flow | -3.32M | 7.50% |
About
Founded
2015
Headquarters
Website
Employees
5